Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (Q37682882)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 2010
edit
Language Label Description Also known as
English
Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer
scientific article published on January 2010

    Statements

    Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer (English)
    1 January 2010
    215-239

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit